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ABSTRACT Tuberculous otitis media and mastoiditis,
or tuberculous otomastoiditis, is a rare but well-described
infectious process occasionally aﬀecting individuals in the
United States but more frequently seen in countries where
tuberculosis is endemic. Infection may be primary and occur
through mucus aspirated through the Eustachian tube.
Alternatively, organisms may secondarily infect the nasopharynx
when expectorated from the lungs and, less frequently, may be
hematogenously spread. Chronic otorrhea and hearing loss are
common symptoms, and extensive perforation of the tympanic
membranes and facial nerve paralysis are routinely described.
Diagnosis is made by direct culture of Mycobacterium
tuberculosis, although more recently, molecular techniques
have been used. Successful treatment of tuberculous
otomastoiditis routinely involves surgical intervention
combined with prolonged antituberculosis therapy.
Tuberculous otitis media and tuberculous mastoiditis
occur together as a single disease process and are re-
ferred to herein as tuberculous otomastoiditis. One year
after the isolation of the tubercle bacillus by Koch in
1882, the organism was cultured from a middle-ear le-
sion. Otologic tuberculosis was relegated to the status
of “other” in the list of localizations of tuberculosis by
the American Thoracic Society in their 1981 Diagnostic
Standards and Classiﬁcation of Tuberculosis and Other
Mycobacterial Diseases (1) and receives no mention in
more recent guidelines (2). Presumably, it was given this
status because tuberculosis of the ear is extremely un-
common in the United States (11 cases reported from
1990 through 2003) (3). However, there are still occa-
sional patients who have chronically draining ears due
to Mycobacterium tuberculosis infection (4). Addition-
ally, tuberculosis remains a problem in the United States,
as overall incidence has plateaued and reported cases
have recently increased (5). These increasing numbers
of tuberculosis cases in both U.S.- and foreign-born
populations coupled with growing rates of immuno-
suppressed patients, such as transplant recipients, those
receiving tumor necrosis factor alpha inhibitors, and
those with human immunodeﬁciency virus infection, will
likely spawn other cases of tuberculous otomastoiditis;
therefore, a brief summary of the problem is justiﬁed.
INCIDENCE
Overall, Mycobacterium tuberculosis is the implicated
pathogen in 0.05% to 0.9% of chronic middle-ear
infections (6). Most of the medical literature on tuber-
culous otomastoiditis is from Europe, Africa, and Asia,
where the disease is more prevalent. Between 1967 and
1979, 4,000 biological specimens of the middle ear
were examined in Tübingen, Germany. Tuberculosis
was found in 14 (0.1%), the youngest patient being
10 months old and the oldest 69 years old (7). In a re-
view of patients at Massachusetts General Hospital and
the Massachusetts Eye and Ear Inﬁrmary from 1962
through 1984, there were four cases of tuberculous
otomastoiditis out of 6,310 cases (0.06%) of chronic
otitis media and out of 1,850 cases of tuberculosis (8).
Vaamonde et al. diagnosed 10 cases from 1996 to 2002
in Spain (6). A more recent study from Turkey found
tuberculous otomastoiditis in 11 of 32 (34%) patients
with tuberculous meningitis (9). Laryngitis and otitis
media remain the most frequent ear, nose, and throat
diseases of tuberculous origin (10).
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PATHOGENESIS AND PATHOLOGY
Tuberculosis of the middle ear may be a primary infec-
tion in the area of the shorter and large-bored Eustachian
tube in neonates who have aspirated infected amniotic
ﬂuid. Similarly, in older patients, infection may ascend
from the upper respiratory tract by mucus aspirated
through the Eustachian tube. Cases may occur second-
arily, however, when organisms are coughed into the
nasopharynx from pulmonary lesions or as the result
of hematogenous spread (11). Preauricular or anterior
cervical lymphadenopathy and facial nerve paralysis
occur infrequently but are more likely with tuberculous
than other types of bacterial otitis media.
Pathologically, the disease always involves the mucosa
ﬁrst, with extensive edema, inﬁltration by round and
giant cells, granuloma formation, and, ﬁnally, caseation.
Histopathology may be altered in immunocompromised
patients. Thickening of the tympanic membrane is fol-
lowed by perforation with associated destruction of the
ossicles and purulent discharge. Secondarily, the perios-
teum becomes involved, followed months later by bone
necrosis with resultant complications that are similar to
those occurring with other infections of the middle ear
and mastoid. The labyrinth appears to be at greatest
risk in adults, and the facial nerve and meninges are the
greatest risk areas in children (12). Hearing loss with a
large neurosensory component is frequent in all patients.
DIAGNOSIS
The history and physical ﬁndings in both primary and
secondary tuberculous otomastoiditis are frequently
nonspeciﬁc. In secondary disease, the classic ﬁndings
of chronic ear infection (otorrhea, absence of pain, and
profound hearing loss) may not be well deﬁned, as
concomitant bacterial superinfection is frequently pres-
ent (13). An exception is damage to the facial nerve,
paralysis of which is usually associated with tuberculo-
sis. Tympanic membranes are often extensively dam-
aged, with one or more perforations. Older patients may
complain of tinnitus and “funny noises” (14).
Tuberculous otomastoiditis has to be considered in
the differential diagnosis of chronic otitis media in tu-
berculous patients as well as in those who have no evi-
dence of tuberculosis elsewhere and whose otorrhea
does not improve with the usual medical treatment. A
history of tuberculosis in a family member should arouse
suspicion and lead to conﬁrmatory studies. Tuberculin
skin testing and gamma interferon release assays for
tuberculosis in children and adults with chronic otor-
rhea may be helpful, although results may be falsely
negative (15–17). The diagnosis of tuberculous otoma-
stoiditis is considered conﬁrmed by culture ofM. tuber-
culosis from the local discharge or a biopsy sample.
However, the diagnosis can be assumed if pulmonary
tuberculosis is conﬁrmed to be associated with chronic
otomastoiditis in the absence of other pathogens. Posi-
tive acid-fast staining (auramine and Ziehl-Neelsen) of
otorrhea is strongly suggestive. Nucleic acid ampliﬁ-
cation techniques (PCR) may be useful for patients for
whom acid-fast stains are negative (18). Recently, Xpert
MTB/RIF (Cepheid, Inc., Sunnyvale, CA), a real-time
PCR test, identiﬁed infection when performed on an
otorrhea sample (19). Histopathological study of tissue
as well as improvement following speciﬁc antituber-
culosis therapy may support the diagnosis.
Primary tuberculosis of the middle ear is most difﬁcult
to diagnose. The tympanic membrane before perfora-
tion is swollen, yellowish, and hyperemic. Perforation
follows in the untreated patient and may present as
multiple perforations in 20% to 30% of those infected.
In tuberculous otomastoiditis of both the primary and
secondary types, abnormalities on X-ray ﬁlms of the
mastoid are less common than with other types of
chronic otomastoiditis, but a computed tomography
scan showing soft tissue ﬁlling the entire tympanum and
mastoid air cells and cortical bone destruction without
evidence of cholesteatoma is suggestive of tuberculous
otomastoiditis (20). Propagation to the inner ear may
occur in older children and adults when the disease is
subacute and is manifested by slowly progressive hear-
ing loss (initially of the high tones) as a result of cochlear
destruction. Extension and hematogenous dissemination
from tuberculous otomastoiditis are rare, as evidenced
by the frequent chronicity of the disease for many years
without such spread (6). The dura mater usually resists
direct extension to the brain; however, tuberculous
meningitis is deﬁnitely associated with chronic tubercu-
lous otomastoiditis (9, 21, 22). Evaluation for pulmo-
nary involvement can be useful, as up to 50% of patients
with tuberculous otomastoiditis may have X-ray evi-
dence of pulmonary tuberculosis (11).
The frequencies of signs and symptoms in patients
with tuberculous otomastoiditis historically and during
more recent periods are shown in Table 1.
Differential diagnosis is broad, including histoplas-
mosis, North American blastomycosis, South American
blastomycosis, syphilis, midline granulomas (lethal),
granulomatosis with polyangiitis (Wegener’s), sarcoido-
sis, histiocytosis X, eosinophilic granuloma, nocardiosis,
necrotizing external otitis, lymphoma, nontuberculous
mycobacterial infection, and cholesteatoma.
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TREATMENT
Once the diagnosis of tuberculous otomastoiditis is
made, the combined talents of the primary care physi-
cian, an ear, nose, and throat surgeon, and an infectious
disease specialist are required for optimum therapy.
Isoniazid plus rifampin is the preferred antituberculosis
therapy, with pyrazinamide added for the ﬁrst 2 months.
Ethambutol is also usually given until resistant M. tu-
berculosis is ruled out. Final therapy is based on in vitro
susceptibility studies. There have now been at least 12
cases of tuberculous otomastoiditis treated with short-
course therapy with favorable responses. Ten were
treated with isoniazid, rifampin, and pyrazinamide for
2 months, followed by 4 months (eight patients) or 7
months (two patients) of isoniazid plus rifampin. Two
other patients (23) received isoniazid, rifampin, etham-
butol, and pyrazinamide for 9 months. There are not
enough cases of tuberculous otomastoiditis to conduct
any treatment trials, but based on reported data, most
patients should be treated medically for 6 to 9 months.
In addition to obtaining tissue for diagnosis, the sur-
geon may have a role in therapy by removing a nidus of
infected debris. Complications mandating surgical ap-
proach include facial nerve paralysis, subperiosteal ab-
scess, labyrinthitis, persistent postauricular ﬁstula, and
extension of infection into the central nervous system
(24). After therapy is completed, reconstructive proce-
dures may improve hearing in certain patients.
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